Shanghai ZJ Bio-Tech Co (SHSE:688317) Marketable Securities: ¥403.5 Mil (As of Mar. 2026)


SHSE:688317 Shanghai ZJ Bio-Tech Co Ltd SHSE:688317
64 GF Score
Price ¥15.34
GF Value ¥9.87
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Shanghai ZJ Bio-Tech Co Marketable Securities?

Shanghai ZJ Bio-Tech Co SHSE:688317 -2.04% 64 Marketable Securities is ¥403.5 Mil as of Mar. 2026. GuruFocus rates SHSE:688317 with a GF Score™ of 64/100 and a GF Value™ of ¥9.87 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Shanghai ZJ Bio-Tech Co's Marketable Securities for the quarter that ended in Mar. 2026 was ¥403.5 Mil.

Shanghai ZJ Bio-Tech Co's annual Marketable Securities stayed the same from Dec. 2023 (¥0.0 Mil) to Dec. 2024 (¥0.0 Mil) but then increased from Dec. 2024 (¥0.0 Mil) to Dec. 2025 (¥347.9 Mil).

Shanghai ZJ Bio-Tech Co  (SHSE:688317) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Shanghai ZJ Bio-Tech Co Marketable Securities Related Terms

Shanghai ZJ Bio-Tech Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Shanghai ZJ Bio-Tech Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai ZJ Bio-Tech Co Marketable Securities Chart

Shanghai ZJ Bio-Tech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 347.89

Shanghai ZJ Bio-Tech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 148.71 312.80 354.30 347.89 403.46
SHSE:688317
64GF Score
Shanghai ZJ Bio-Tech Co Ltd SHSE:688317
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai ZJ Bio-Tech Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ¥403.5 Mil mean?
Shanghai ZJ Bio-Tech Co (SHSE:688317) has a Marketable Securities of ¥403.5 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Shanghai ZJ Bio-Tech Co and its competitors.
Is Shanghai ZJ Bio-Tech Co's Marketable Securities too high?
Shanghai ZJ Bio-Tech Co's current Marketable Securities is ¥403.5 Mil. Overall, Shanghai ZJ Bio-Tech Co has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai ZJ Bio-Tech Co's Marketable Securities compare to ABT and SYK?
Shanghai ZJ Bio-Tech Co's Marketable Securities of ¥403.5 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Shanghai ZJ Bio-Tech Co and its competitors. Shanghai ZJ Bio-Tech Co's current Marketable Securities is ¥403.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai ZJ Bio-Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai ZJ Bio-Tech Co (SHSE:688317) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥9.87, compared to a current price of ¥15.34 — trading 55.4% above its estimated fair value. The current Marketable Securities is ¥403.5 Mil. Shanghai ZJ Bio-Tech Co's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Shanghai ZJ Bio-Tech Co (SHSE:688317), the current Marketable Securities is ¥403.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai ZJ Bio-Tech Co (SHSE:688317) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai ZJ Bio-Tech Co stock appears to be overvalued. The current stock price of ¥15.34 is trading 55.4% above its estimated GF Value™ of ¥9.87. GuruFocus considers Shanghai ZJ Bio-Tech Co to be Significantly Overvalued.

Key valuation signals for SHSE:688317:

  • Marketable Securities: ¥403.5 Mil
  • GF Value™: ¥9.87 vs. price of ¥15.34 (55.4% above fair value)
  • GF Score™: 64/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688317 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai ZJ Bio-Tech Co Business Description

Address No. 588 Xinjun Ring Road, Building 26, Pujiang Hi-Tech Park, Caohejing Development Zone, Shanghai, CHN
Shanghai ZJ Bio-Tech Co Ltd is engaged in research and development, production and sales of genetic diagnostic reagents and instruments and equipment. The rapid real-time fluorescent PCR diagnostic test reagents developed by the company are mainly used in clinical medicine, public health emergencies, entry-exit inspection and quarantine, food inspection, animal husbandry, aquaculture and other fields.
64GF Score

Get the complete analysis for SHSE:688317

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.34
Price
¥9.87
GF Value